30
KIT
was yet to be launched. Today,
our portfolio of real-time CGM
sensors [rt-CGM, essentially this
means it did not rely on people
scanning their sensors, these 'flash'
sensors get called is-CGM where 'is'
stands for intermittent scanning]
reliably deliver accurate glucose
readings direct to over 130 different
smartphones, as well as offering
real-time readings displayed on a
smartwatch or separate receiver,
should our users prefer that option.
"Since 1999, we've been able to
show our users their glucose data
accurately in real-time, helping
to ease the burden of living with
diabetes - glucose readings at your
fingertips, with no fingerpricks.
We've built our sensors from the
ground up, with both real-time
technology and our end-users,
in mind.
"As technology gathers pace, we
continue to innovate and find new
options that ease the burden of
diabetes for our existing and future
customers. Today, people walk
around with more computing power
in their pocket than NASA had to land
Apollo 11 on the moon, and how we
utilise these advances in technology
for the diabetes community is always
at the forefront of our innovation.
"Our real-time CGM portfolio has
also been designed with our users'
and their care teams mind. We want
to make sure our products are easy
to start, simple to keep using, and
fit seamlessly into someone's life. It's
fair to say that in the years that have
followed our first rtCGM sensor, we
have learned a lot about how this
technology works, and what our
users expect from us.
From continuously adding to our
connected systems and technology
ecosystem to creating a smaller,
and more discrete, form factor, we
are listening to what our customers
want, and continuing to innovate."
Medtronic
Andrea Park, writing for Fierce
Biotech on 25 September 2023,
reported, "Medtronic simplifies
diabetes line-up with European
CALLS TO ACTION
LDC's Research Registry
Join Leicester's Research Registry today! According to Professor Pratik Choudhary at Leicester Diabetes
Centre, "We have so many studies coming through around novel treatments for both Type 1 and Type 2
diabetes, being part of this registry means you will have the chance to be part of those studies."
Give researchers permission to connect with you for exciting clinical research opportunities at
Leicester's Hospitals. Your participation can help shape the future of diabetes care. To sign up now,
click HERE.
Speak up for tech!
It's time to speak up and speak out about diabetes tech, says Diabetes UK. NICE iss about to finalise their
decision on who's able to access Hybrid Closed Loop (HCL) and NHS England is making plans on the roll out.
A HCL or 'artificial pancreas', works by linking insulin pumps and continuous glucose monitors (CGM) with
a computer algorithm that calculates the amount of insulin someone needs based on blood sugar readings.
Join the charity in calling on the Government to make sure HCL is properly funded so local services and
systems can deliver them across the country. To message Steve Barclay, Secretary of State for Health and
Social Care, click HERE.